Mehmet Ilktac

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Pseudomonas Aeruginosa

Coronary Artery Disease

Long Noncoding Rna

Top Venues

Biotechnology and applied biochemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Dena Najafi, Goli Siri, Maryam Sadri, Omid Yazdani, Romina Esbati, Parvin Karimi, Ali Keshavarz, Amirreza Mehmandar-Oskuie, Mehmet Ilktac
Combination MEG3 lncRNA and Ciprofloxacin dramatically decreases cell migration and viability as well as induces apoptosis in GC cells in vitro. Biotechnology and applied biochemistry 71 (4) (2024)
Dena Najafi, Goli Siri, Maryam Sadri, Omid Yazdani, Romina Esbati, Parvin Karimi, Ali Keshavarz, Amirreza Mehmandar-Oskuie, Mehmet Ilktac
Combination MEG3 lncRNA and Ciprofloxacin dramatically decreases cell migration and viability as well as induces apoptosis in GC cells in vitro. Biotechnology and applied biochemistry 71 (4) (2024)
Dena Najafi, Goli Siri, Maryam Sadri, Omid Yazdani, Romina Esbati, Parvin Karimi, Ali Keshavarz, Amirreza Mehmandar-Oskuie, Mehmet Ilktac
Combination MEG3 lncRNA and Ciprofloxacin dramatically decreases cell migration and viability as well as induces apoptosis in GC cells in vitro. Biotechnology and applied biochemistry (2024)